{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:19:13Z","timestamp":1791235153160,"version":"4.1.0"},"reference-count":91,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2,1]]},"DOI":"10.1093\/aje\/kwk015","type":"journal-article","created":{"date-parts":[[2006,11,17]],"date-time":"2006-11-17T02:15:27Z","timestamp":1163729727000},"page":"235-245","source":"Crossref","is-referenced-by-count":93,"title":["Variants in Estrogen Biosynthesis Genes, Sex Steroid Hormone Levels, and Endometrial Cancer: A HuGE Review"],"prefix":"10.1093","volume":"165","author":[{"given":"Sara H.","family":"Olson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa V.","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Orlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,11,16]]},"reference":[{"key":"key\n\t\t\t\t20170522160203_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/modpathol.3880051","article-title":"Theories of endometrial carcinogenesis: a multidisciplinary approach","volume":"13","author":"Sherman","year":"2000","journal-title":"Mod Pathol"},{"key":"key\n\t\t\t\t20170522160203_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bjc.1988.44","article-title":"The dose-effect relationship between \u2018unopposed\u2019 oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk","volume":"57","author":"Key","year":"1988","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20170522160203_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ijc.11529","article-title":"Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women","volume":"108","author":"Lukanova","year":"2004","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20170522160203_bib4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/88.16.1127","article-title":"Case-control study of endogenous steroid hormones and endometrial cancer","volume":"88","author":"Potischman","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170522160203_bib5","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170522160203_bib6","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/1055-9965.EPI-04-0815","article-title":"Screening for deleterious nonsynonymous single-nucleotide polymorphisms in genes involved in steroid hormone metabolism and response","volume":"14","author":"Johnson","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170522160203_bib7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0015-0282(98)00511-1","article-title":"Expression of P450c17 messenger ribonucleic acid in postmenopausal human ovary tissues","volume":"71","author":"Jose","year":"1999","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170522160203_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/107155760301000108","article-title":"Expression of messenger ribonucleic acid encoding steroidogenic enzymes in postmenopausal ovaries","volume":"10","author":"Nagamani","year":"2003","journal-title":"J Soc Gynecol Investig"},{"key":"key\n\t\t\t\t20170522160203_bib9","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/hmg\/3.10.1873","article-title":"Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17.","volume":"3","author":"Carey","year":"1994","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170522160203_bib10","first-page":"2825","article-title":"CYP17 and breast cancer risk: the polymorphism in the 5\u2032 flanking area of the gene does not influence binding to Sp-1","volume":"59","author":"Nedelcheva Kristensen","year":"1999","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170522160203_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.ejhg.5201101","article-title":"Comprehensive evaluation of the association between prostate cancer and genotypes\/haplotypes in CYP17A1, CYP3A4, and SRD5A2","volume":"12","author":"Loukola","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"key\n\t\t\t\t20170522160203_bib12","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/1055-9965.EPI-05-0343","article-title":"Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk","volume":"14","author":"Skibola","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170522160203_bib13","doi-asserted-by":"crossref","first-page":"42795","DOI":"10.1074\/jbc.M208537200","article-title":"Structure\/function relationships responsible for the kinetic differences between human type 1 and type 2 3beta-hydroxysteroid dehydrogenase and for the catalysis of the type 1 activity","volume":"277","author":"Thomas","year":"2002","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170522160203_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/emm.2003.22","article-title":"Expression of 3beta-hydroxysteroid dehydrogenase and P450 side chain cleavage enzyme in the human uterine endometrium","volume":"35","author":"Rhee","year":"2003","journal-title":"Exp Mol Med"},{"key":"key\n\t\t\t\t20170522160203_bib15","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1210\/jcem.86.12.8082","article-title":"Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells","volume":"86","author":"Tsai","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170522160203_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1097-0045(19970915)33:1<9::AID-PROS2>3.0.CO;2-H","article-title":"Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial\/ethnic groups: implications for prostate cancer risk","volume":"33","author":"Devgan","year":"1997","journal-title":"Prostate"},{"key":"key\n\t\t\t\t20170522160203_bib17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/hmg\/3.2.384","article-title":"Dinucleotide repeat polymorphisms in the HSD3B2 gene","volume":"3","author":"Verreault","year":"1994","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170522160203_bib18","first-page":"428","article-title":"Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age","volume":"78","author":"Bulun","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170522160203_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1096\/fasebj.11.1.9034163","article-title":"Cytochromes P450 11: expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage","volume":"11","author":"Simpson","year":"1997","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20170522160203_bib20","first-page":"1831","article-title":"CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors","volume":"79","author":"Bulun","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170522160203_bib21","first-page":"491","article-title":"Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies","volume":"146","author":"Watanabe","year":"1995","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170522160203_bib22","first-page":"115","article-title":"CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease","volume":"52","author":"Berstein","year":"2005","journal-title":"Neoplasma"},{"key":"key\n\t\t\t\t20170522160203_bib23","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ajog.2005.01.009","article-title":"Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis","volume":"192","author":"Fowler","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20170522160203_bib24","first-page":"215","article-title":"No association between a single nucleotide polymorphism in CYP19 and breast cancer risk","volume":"11","author":"Haiman","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170522160203_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00223-002-2158-3","article-title":"Polymorphisms in the CYP19 and AR genes\u2014relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study","volume":"74","author":"Tofteng","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t20170522160203_bib26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/sj.bjc.6690071","article-title":"Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk","volume":"79","author":"Siegelmann-Danieli","year":"1999","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20170522160203_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ijc.21041","article-title":"CYP19 (aromatase) haplotypes and endometrial cancer risk","volume":"116","author":"Paynter","year":"2005","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20170522160203_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/carcin\/21.2.189","article-title":"Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk","volume":"21","author":"Healey","year":"2000","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20170522160203_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/carcin\/22.2.347","article-title":"Polymorphic variation in CYP19 and the risk of breast cancer","volume":"22","author":"Baxter","year":"2001","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20170522160203_bib30","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddg294","article-title":"A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort","volume":"12","author":"Haiman","year":"2003","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170522160203_bib31","doi-asserted-by":"crossref","first-page":"11071","DOI":"10.1158\/0008-5472.CAN-05-1218","article-title":"Human aromatase: gene resequencing and functional genomics","volume":"65","author":"Ma","year":"2005","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170522160203_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0250001","article-title":"Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease","volume":"25","author":"Labrie","year":"2000","journal-title":"J Mol Endocrinol"},{"key":"key\n\t\t\t\t20170522160203_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1158\/1055-9965.EPI-03-0241","article-title":"HSD17B1 gene polymorphisms and risk of endometrial and breast cancer","volume":"13","author":"Setiawan","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170522160203_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/hmg\/2.4.479","article-title":"Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid dehydrogenase II gene at the EDH17B2 locus on 17q11-q21","volume":"2","author":"Normand","year":"1993","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170522160203_bib35","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1371\/journal.pgen.0010068","article-title":"Genetic variation in the HSD17B1 gene and risk of prostate cancer","volume":"1","author":"Kraft","year":"2005","journal-title":"PLoS Genet"},{"key":"key\n\t\t\t\t20170522160203_bib36","volume-title":"Cancer facts & figures 2006","author":"American Cancer Society","year":"2006"},{"key":"key\n\t\t\t\t20170522160203_bib37","article-title":"Cancer of the uterine body","volume-title":"Cancer: principles & practice of oncology","author":"Burke","year":"2001"},{"key":"key\n\t\t\t\t20170522160203_bib38","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/jnci\/dji378","article-title":"Impact of hysterectomy on endometrial carcinoma rates in the United States","volume":"97","author":"Sherman","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170522160203_bib39","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone-replacement therapy in the Million Women Study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522160203_bib40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/1047-2797(93)90035-3","article-title":"Postmenopausal unopposed estrogens. Characteristics of use in relation to the risk of endometrial carcinoma","volume":"3","author":"Herrinton","year":"1993","journal-title":"Ann Epidemiol"},{"key":"key\n\t\t\t\t20170522160203_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0029-7844(97)00577-2","article-title":"Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens","volume":"91","author":"Cushing","year":"1998","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20170522160203_bib42","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","article-title":"Risk of endometrial cancer following estrogen replacement with and without progestins","volume":"91","author":"Weiderpass","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170522160203_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0090-8258(91)90246-2","article-title":"The epidemiology of endometrial cancer","volume":"41","author":"Parazzini","year":"1991","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20170522160203_bib44","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20170522160203_bib45","article-title":"Endometrial cancer","volume-title":"Textbook of cancer epidemiology","author":"Persson","year":"2002"},{"key":"key\n\t\t\t\t20170522160203_bib46","volume-title":"IARC handbooks of cancer prevention","author":"Weight control and physical activity","year":"2002"},{"key":"key\n\t\t\t\t20170522160203_bib47","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/oxfordjournals.aje.a115234","article-title":"The epidemiology of serum sex hormones in postmenopausal women","volume":"129","author":"Cauley","year":"1989","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170522160203_bib48","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jnci\/87.17.1297","article-title":"Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women","volume":"87","author":"Hankinson","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170522160203_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1008929714862","article-title":"Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom)","volume":"12","author":"Verkasalo","year":"2001","journal-title":"Cancer Causes Control"},{"key":"key\n\t\t\t\t20170522160203_bib50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1008838412423","article-title":"Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States)","volume":"9","author":"Madigan","year":"1998","journal-title":"Cancer Causes Control"},{"key":"key\n\t\t\t\t20170522160203_bib51","first-page":"65","article-title":"Aromatase inhibitors as potential cancer chemopreventives","volume":"7","author":"Kelloff","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170522160203_bib52","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1055\/s-2007-978681","article-title":"Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women","volume":"32","author":"Tchernof","year":"2000","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t20170522160203_bib53","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/0002-9378(93)90260-P","article-title":"A case-control study of endometrial cancer in relation to cigarette smoking, serum estrogen levels, and alcohol use","volume":"169","author":"Austin","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20170522160203_bib54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1210\/jc.2003-030164","article-title":"Polymorphisms in the P450 c17 (17-hydroxylase\/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women","volume":"89","author":"Somner","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170522160203_bib55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF02968046","article-title":"CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer","volume":"11","author":"Chacko","year":"2004","journal-title":"Breast Cancer"},{"key":"key\n\t\t\t\t20170522160203_bib56","first-page":"4174","article-title":"5\u2032 polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. (Letter)","volume":"81","author":"Gharani","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170522160203_bib57","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bone.2005.01.004","article-title":"Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density","volume":"36","author":"Riancho","year":"2005","journal-title":"Bone"},{"key":"key\n\t\t\t\t20170522160203_bib58","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1093\/humrep\/dei054","article-title":"CYP17 genotype predicts serum hormone levels among pre-menopausal women","volume":"20","author":"Small","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170522160203_bib59","first-page":"1015","article-title":"The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer","volume":"59","author":"Haiman","year":"1999","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170522160203_bib60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3835(02)00019-8","article-title":"CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?","volume":"180","author":"Berstein","year":"2002","journal-title":"Cancer Lett"},{"key":"key\n\t\t\t\t20170522160203_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s004320000200","article-title":"CYP19 gene polymorphism in endometrial cancer patients","volume":"127","author":"Berstein","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"key\n\t\t\t\t20170522160203_bib62","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0015-0282(01)02999-5","article-title":"Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase\/C(17\u201320) lyase promoters","volume":"77","author":"Daneshmand","year":"2002","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170522160203_bib63","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/6.3.397","article-title":"Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism","volume":"6","author":"Gharani","year":"1997","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170522160203_bib64","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0015-0282(99)00628-7","article-title":"Microsatellite polymorphism (tttta)(n) at \u2212528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome","volume":"73","author":"Diamanti-Kandarakis","year":"2000","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170522160203_bib65","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/ijc.10651","article-title":"Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women","volume":"102","author":"Garcia-Closas","year":"2002","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20170522160203_bib66","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1210\/jc.2003-031640","article-title":"Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone","volume":"89","author":"Gaasenbeek","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170522160203_bib67","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/1055-9965.709.13.5","article-title":"Population-based case-control study of CYP11A gene polymorphism and breast cancer risk","volume":"13","author":"Zheng","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170522160203_bib68","first-page":"585","article-title":"Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations","volume":"58","author":"Feigelson","year":"1998","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170522160203_bib69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10549-004-0780-7","article-title":"Association between the T27C polymorphism in the cytochrome P450 c17alpha (CYP17) gene and risk factors for breast cancer","volume":"88","author":"Hong","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t20170522160203_bib70","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djh167","article-title":"Polymorphisms associated with circulating sex hormone levels in postmenopausal women","volume":"96","author":"Dunning","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170522160203_bib71","first-page":"3955","article-title":"A polymorphism in CYP17 and endometrial cancer risk","volume":"61","author":"Haiman","year":"2001","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170522160203_bib72","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/1055-9965.EPI-03-0026","article-title":"Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women","volume":"13","author":"Tworoger","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170522160203_bib73","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.fertnstert.2004.05.068","article-title":"Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome","volume":"82","author":"Kahsar-Miller","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170522160203_bib74","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0015-0282(98)00512-3","article-title":"Polymorphism T\u2192C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome","volume":"71","author":"Diamanti-Kandarakis","year":"1999","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170522160203_bib75","first-page":"123","article-title":"Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5\u2032-UTR in patients with polycystic ovarian syndrome","volume":"15","author":"Marszalek","year":"2001","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20170522160203_bib76","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/1055-9965.EPI-04-0746","article-title":"Association of genetic polymorphisms with serum estrogens measured multiple times during a 2-year period in premenopausal women","volume":"14","author":"Lurie","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170522160203_bib77","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1158\/1055-9965.2282.13.12","article-title":"No association of polymorphisms in CYP17, CYP19, and HSD17-B1 with plasma estradiol concentrations in 1,090 British women","volume":"13","author":"Travis","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170522160203_bib78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2004.01.001","article-title":"CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity","volume":"207","author":"Berstein","year":"2004","journal-title":"Cancer Lett"},{"key":"key\n\t\t\t\t20170522160203_bib79","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1525-1438.2006.00417.x","article-title":"CYP17 genetic polymorphism in patients with endometrial hyperplasia and cancer","volume":"16","author":"Aban","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"key\n\t\t\t\t20170522160203_bib80","first-page":"35","article-title":"The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients","volume":"57","author":"Szyllo","year":"2006","journal-title":"Pol J Pathol"},{"key":"key\n\t\t\t\t20170522160203_bib81","first-page":"848","article-title":"Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotype","volume":"61","author":"McKean-Cowdin","year":"2001","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170522160203_bib82","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/1097-0215(20000715)87:2<204::AID-IJC8>3.0.CO;2-3","article-title":"A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk","volume":"87","author":"Haiman","year":"2000","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20170522160203_bib83","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/07853890310006370","article-title":"Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women","volume":"35","author":"Salmen","year":"2003","journal-title":"Ann Med"},{"key":"key\n\t\t\t\t20170522160203_bib84","doi-asserted-by":"crossref","first-page":"E989","DOI":"10.1152\/ajpendo.00550.2004","article-title":"Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women","volume":"288","author":"Dick","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t20170522160203_bib85","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1677\/erc.0.0060165","article-title":"Aromatase and breast cancer susceptibility","volume":"6","author":"Probst-Hensch","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t20170522160203_bib86","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/oby.2003.81","article-title":"The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women","volume":"11","author":"Baghaei","year":"2003","journal-title":"Obes Res"},{"key":"key\n\t\t\t\t20170522160203_bib87","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.ejca.2003.08.017","article-title":"Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk","volume":"39","author":"Miyoshi","year":"2003","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t20170522160203_bib88","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/deh900","article-title":"Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women","volume":"20","author":"Petry","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170522160203_bib89","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/aje\/kwh287","article-title":"CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors: a HuGE review","volume":"160","author":"Sharp","year":"2004","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170522160203_bib90","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1095\/biolreprod56.4.789","article-title":"The role of cytochrome P450 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase in the integration of gonadal and adrenal steroidogenesis via the delta 5 and delta 4 pathways of steroidogenesis in mammals","volume":"56","author":"Conley","year":"1997","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170522160203_bib91","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/bi9821059","article-title":"Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species","volume":"38","author":"Brock","year":"1999","journal-title":"Biochemistry"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/165\/3\/235\/17337337\/kwk015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T09:32:39Z","timestamp":1707384759000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article-lookup\/doi\/10.1093\/aje\/kwk015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,16]]},"references-count":91,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,11,16]]},"published-print":{"date-parts":[[2007,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwk015","relation":{},"ISSN":["1476-6256","0002-9262"],"issn-type":[{"value":"1476-6256","type":"electronic"},{"value":"0002-9262","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11,16]]}}}